Artemisinin resistance at the China-Myanmar border and association with mutations in the K13 propeller gene.

Antimicrobial Agents and Chemotherapy
Zenglei WangLiwang Cui

Abstract

Artemisinin resistance in Plasmodium falciparum parasites in Southeast Asia is a major concern for malaria control. Its emergence at the China-Myanmar border, where there have been more than 3 decades of artemisinin use, has yet to be investigated. Here, we comprehensively evaluated the potential emergence of artemisinin resistance and antimalarial drug resistance status in P. falciparum using data and parasites from three previous efficacy studies in this region. These efficacy studies of dihydroartemisinin-piperaquine combination and artesunate monotherapy of uncomplicated falciparum malaria in 248 P. falciparum patients showed an overall 28-day adequate clinical and parasitological response of >95% and day 3 parasite-positive rates of 6.3 to 23.1%. Comparison of the 57 K13 sequences (24 and 33 from day 3 parasite-positive and -negative cases, respectively) identified nine point mutations in 38 (66.7%) samples, of which F446I (49.1%) and an N-terminal NN insertion (86.0%) were predominant. K13 propeller mutations collectively, the F446I mutation alone, and the NN insertion all were significantly associated with day 3 parasite positivity. Increased ring-stage survival determined using the ring-stage survival assay (RSA) was hi...Continue Reading

Citations

Nov 10, 2015·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·C PutaporntipA L Hughes
Feb 26, 2016·Malaria Journal·Aye A WinSasithon Pukrittayakamee
Jul 21, 2016·Emerging Infectious Diseases·Mikael BoulléFrançois Nosten
Sep 11, 2016·FEMS Microbiology Reviews·Charles J Woodrow, Nicholas J White
Nov 9, 2016·Malaria Journal·Krongkan SrimuangUNKNOWN Tracking Resistance to Artemisinin Collaboration
Feb 10, 2017·Trends in Parasitology·Sarah K VolkmanDaniel L Hartl
Dec 9, 2016·The American Journal of Tropical Medicine and Hygiene·Valentine DuruDidier Ménard
Apr 25, 2018·Malaria Journal·Laurence Vachot-GanéeDidier Ménard
Apr 28, 2017·Clinical Microbiology Reviews·Abebe Genetu BayihDylan R Pillai
Apr 3, 2019·PloS One·Maria Carmina PauFrancesco Michelangelo Turrini
Sep 10, 2020·Annual Review of Microbiology·Frances Rocamora, Elizabeth A Winzeler
Dec 28, 2016·Molecular Biology and Evolution·Timothy J C AndersonFrançois Nosten
Jul 25, 2019·Antimicrobial Agents and Chemotherapy·Rimi ChakrabartiPradipsinh K Rathod
Dec 4, 2016·Malaria Journal·Neelima MishraNeena Valecha
Sep 25, 2020·Nature Communications·Clare R HardingSebastian Lourido
Apr 23, 2019·International Journal for Parasitology. Drugs and Drug Resistance·Jie ZhangZhaoqing Yang
Jan 26, 2021·Frontiers in Cellular and Infection Microbiology·Fang HuangChristopher V Plowe
Dec 1, 2019·Phytochemistry Reviews : Proceedings of the Phytochemical Society of Europe·B M GruessnerP J Weathers
Jun 24, 2016·Microbiology Spectrum·Rick M Fairhurst, Arjen M Dondorp
Aug 12, 2021·The Journal of Antimicrobial Chemotherapy·Luana C MathieuLise Musset

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.